Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening
Objectives: Cancer and diabetes are two diseases known to bypass socio-demographic segregation, hence the increased focus on their molecular mechanism for therapeutic intervention. Their connection was unclear using traditional biomedical methods until omics technology shows how specific aetiologica...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Informatics in Medicine Unlocked |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914823001880 |
| _version_ | 1827780419891757056 |
|---|---|
| author | Christopher Busayo Olowosoke Tope Abraham Ibisanmi Chioma Joy Eze Abayomi Abiodun Shofunde Tomiwa Lois Olubena Olalekan Akadiri |
| author_facet | Christopher Busayo Olowosoke Tope Abraham Ibisanmi Chioma Joy Eze Abayomi Abiodun Shofunde Tomiwa Lois Olubena Olalekan Akadiri |
| author_sort | Christopher Busayo Olowosoke |
| collection | DOAJ |
| description | Objectives: Cancer and diabetes are two diseases known to bypass socio-demographic segregation, hence the increased focus on their molecular mechanism for therapeutic intervention. Their connection was unclear using traditional biomedical methods until omics technology shows how specific aetiological factors seem to contribute to their initiation and progression. The Genome-wide association study (GWAS) was considered a ground-breaking tool which highlights the roles specific genetic variations like single nucleotide polymorphisms (SNPs) play in the surveillance, diagnosis and treatment of diseases like cancer and diabetes. Methods: While some common missense SNP variants have been investigated and reported, we used bioinformatics tools to predict all known conditions previously reported to link pancreatic cancer and diabetes mellitus subtypes based on metabolism and cell proliferation for their structural and functional significance. The variants were limited to five known genes: epigenetic regulators (EZH2, SIRT1) and pan-peroxisome proliferator-activated receptors (PPARA, PPARD, PPARG). Results: The class filter shows that obesity is a common risk factor. In the result projected, six missense variant rs1232898090, rs1800206, rs1801282, rs1805192 rs121909244 and rs777334819 were discovered to be associated with fifteen different deleterious amino acid point change in the PPARA and PPARG genes. Likewise, the phyre 2 and SwissModel homology modelling analysis revealed proteins with an identifier; 2FVJ, 2P54, 3DZU, 3E00, 4BCR and 6FZG to be common with high alignment coverage and percentage identity for the missense SNP variants. Conclusion: Overall, this analysis provides important insights into how genetic variants can be selected, screened and proposed to inform target selection for other downstream insilico and experimental validation, significant in developing new therapeutics for cancer and diabetes. |
| first_indexed | 2024-03-11T15:05:18Z |
| format | Article |
| id | doaj.art-f15620d388cb4b7298441d6cd272a84e |
| institution | Directory Open Access Journal |
| issn | 2352-9148 |
| language | English |
| last_indexed | 2024-03-11T15:05:18Z |
| publishDate | 2023-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Informatics in Medicine Unlocked |
| spelling | doaj.art-f15620d388cb4b7298441d6cd272a84e2023-10-30T06:05:10ZengElsevierInformatics in Medicine Unlocked2352-91482023-01-0142101342Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screeningChristopher Busayo Olowosoke0Tope Abraham Ibisanmi1Chioma Joy Eze2Abayomi Abiodun Shofunde3Tomiwa Lois Olubena4Olalekan Akadiri5Department of Biotechnology, School of Life Sciences (SLS), Federal University of Technology Akure, P.M.B 704, Akure, Ondo State, Nigeria; Research Development Unit, Institute of Bioinformatics and Molecular Therapeutics, Osogbo, Osun State, Nigeria; Corresponding author. Department of Biotechnology, School of Life Sciences (SLS), Federal University of Technology Akure, P.M.B 704, Akure, Ondo State, Nigeria.Department of Microbiology, School of Life Sciences (SLS), Federal University of Technology Akure, P.M.B 704, Akure, Ondo State, NigeriaResearch Department, Institute of Nursing Research, Osogbo, Osun State, Nigeria; Department of Nursing, Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, NigeriaDepartment of Biotechnology, College of Natural and Applied Sciences (CONAS), Chrisland University, Km 5, Ajebo Road, Abeokuta, Ogun State, NigeriaDepartment of Biotechnology, School of Life Sciences (SLS), Federal University of Technology Akure, P.M.B 704, Akure, Ondo State, NigeriaDepartment of Biotechnology, Molecular Biology and Genetics Laboratory, Federal Institute of Industrial Research Oshodi, P.M.B 21023, Ikeja, Lagos State, NigeriaObjectives: Cancer and diabetes are two diseases known to bypass socio-demographic segregation, hence the increased focus on their molecular mechanism for therapeutic intervention. Their connection was unclear using traditional biomedical methods until omics technology shows how specific aetiological factors seem to contribute to their initiation and progression. The Genome-wide association study (GWAS) was considered a ground-breaking tool which highlights the roles specific genetic variations like single nucleotide polymorphisms (SNPs) play in the surveillance, diagnosis and treatment of diseases like cancer and diabetes. Methods: While some common missense SNP variants have been investigated and reported, we used bioinformatics tools to predict all known conditions previously reported to link pancreatic cancer and diabetes mellitus subtypes based on metabolism and cell proliferation for their structural and functional significance. The variants were limited to five known genes: epigenetic regulators (EZH2, SIRT1) and pan-peroxisome proliferator-activated receptors (PPARA, PPARD, PPARG). Results: The class filter shows that obesity is a common risk factor. In the result projected, six missense variant rs1232898090, rs1800206, rs1801282, rs1805192 rs121909244 and rs777334819 were discovered to be associated with fifteen different deleterious amino acid point change in the PPARA and PPARG genes. Likewise, the phyre 2 and SwissModel homology modelling analysis revealed proteins with an identifier; 2FVJ, 2P54, 3DZU, 3E00, 4BCR and 6FZG to be common with high alignment coverage and percentage identity for the missense SNP variants. Conclusion: Overall, this analysis provides important insights into how genetic variants can be selected, screened and proposed to inform target selection for other downstream insilico and experimental validation, significant in developing new therapeutics for cancer and diabetes.http://www.sciencedirect.com/science/article/pii/S2352914823001880Single nucleotide polymorphismsDiabetes mellitusPancreatic cancerInsilicoModellingPhylogenetic |
| spellingShingle | Christopher Busayo Olowosoke Tope Abraham Ibisanmi Chioma Joy Eze Abayomi Abiodun Shofunde Tomiwa Lois Olubena Olalekan Akadiri Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening Informatics in Medicine Unlocked Single nucleotide polymorphisms Diabetes mellitus Pancreatic cancer Insilico Modelling Phylogenetic |
| title | Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening |
| title_full | Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening |
| title_fullStr | Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening |
| title_full_unstemmed | Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening |
| title_short | Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug screening |
| title_sort | investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease a rationale to selection of targets for insilico drug screening |
| topic | Single nucleotide polymorphisms Diabetes mellitus Pancreatic cancer Insilico Modelling Phylogenetic |
| url | http://www.sciencedirect.com/science/article/pii/S2352914823001880 |
| work_keys_str_mv | AT christopherbusayoolowosoke investigationofpolymorphismroleinproteinstructureandfunctionforselectedcanceranddiabetesdiseasearationaletoselectionoftargetsforinsilicodrugscreening AT topeabrahamibisanmi investigationofpolymorphismroleinproteinstructureandfunctionforselectedcanceranddiabetesdiseasearationaletoselectionoftargetsforinsilicodrugscreening AT chiomajoyeze investigationofpolymorphismroleinproteinstructureandfunctionforselectedcanceranddiabetesdiseasearationaletoselectionoftargetsforinsilicodrugscreening AT abayomiabiodunshofunde investigationofpolymorphismroleinproteinstructureandfunctionforselectedcanceranddiabetesdiseasearationaletoselectionoftargetsforinsilicodrugscreening AT tomiwaloisolubena investigationofpolymorphismroleinproteinstructureandfunctionforselectedcanceranddiabetesdiseasearationaletoselectionoftargetsforinsilicodrugscreening AT olalekanakadiri investigationofpolymorphismroleinproteinstructureandfunctionforselectedcanceranddiabetesdiseasearationaletoselectionoftargetsforinsilicodrugscreening |